Zpráva o průběhu klinického hodnocení KDO_DC1311 Annual Report za období 10. září 2020 ‒ 9. září 2021

Title in English KDO_DC1311 Clinical trial Annual Report for the period September 10, 2020 - September 9, 2021


Year of publication 2021
MU Faculty or unit

Faculty of Medicine

Web KDO_DC1311
Description Combination antitumor therapy with ex vivo manipulated interleukin-12-producing dendritic cells in pediatric, adolescent, and young adult patients with high-risk progressive, relapsed, or primarily metastatic malignancies, protocol number KDO_DC1311.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info